HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Rose Sheet

Executive Summary

Chairman and CEO Ilia Lekach has withdrawn his offer to take the company private, fragrance company reports, noting it plans to file an 8-K with a copy of that notification. Following Lekach's unsolicited offer in June to pay $29 per share, an independent committee of the firm's board of directors responded it was not "prudent" to accept the offer due to "significant financial and other contingencies contained in the proposal" (1"The Rose Sheet" June 19, 2006, In Brief and 2"The Rose Sheet" July 3, 2006, In Brief). Parlux also confirms it has received offers for certain of its brands, and that the offers are being reviewed by the firm's board of directors. Company has not entered into definitive agreements regarding any of the offers, firm notes. Parlux holds the fragrance licenses to brands such as Paris Hilton, Perry Ellis, GUESS?, Maria Sharapova and Ocean Pacific...

You may also be interested in...

Perry Ellis sale

Parlux Fragrances has signed a letter of intent to sell its Perry Ellis fragrance rights to Victory International for $140 mil., company announces Aug. 16. Under terms of the deal, Victory will pay $120 mil. for fragrance rights and $20 mil. for inventory. The letter of intent is subject to the execution of a definitive agreement. Parlux notes the sale is appropriate due to its plans to develop other celebrity fragrance brands. The firm adds that Victory, which has handled distribution for its Fred Hayman Beverly Hills product lines, is the right partner to continue the success of the brand. Victory, which holds the license for the Carlos Santana fragrances, among others, maintains the addition of Perry Ellis will strengthen its portfolio. Parlux recently confirmed it was reviewing offers for certain brands (1"The Rose Sheet" July 24, 2006, In Brief)...


CEO Ilia Lekach has made an unsolicited offer to take the fragrance company private for $29 per share, Parlux announces June 14. In light of the offer, the company has cancelled its annual investors day scheduled for June 23, firm notes. Parlux revealed in July 2005 that it was considering a sale of the company as part of an initiative to explore "various strategic alternatives to enhance shareholder value" (1"The Rose Sheet" July 18, 2005, In Brief). Separately, company released unaudited fiscal 2006 (ended March 31) results on June 13. Parlux reports net sales increased 82% to $182.2 mil., while net income advanced 109% to $22.5 mil., in line with preliminary results reported in May (2"The Rose Sheet" May 15, 2006, In Brief). On June 9, Parlux filed an extension for its annual report for the fiscal year, because it was unable to complete certain new requirements by the initial filing date. Firm noted "certain internal controls were not operating effectively as of and during the year" and that it is taking "immediate action to address and remediate" the issues...

Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases

Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts